CORT Competitors & Alternatives
Compare Corcept Therapeutics Incorporated with similar stocks in the same industry
Biotechnology
CORT
Main Stock$46.52
Tradestie Score
67
Market Cap
$8.88B
P/E Ratio
56.8
Revenue Growth
0.1%
Analyst Upside
+44.9%
Top Competitors
219 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
CRSP
CRISPR Therapeutics AG
|
$52.34
|
$6.02B | - | 53 | Compare |
|
NUVL
Nuvalent, Inc. Class A Common Stock
|
$100.28
|
$5.95B | - | 55 | Compare |
|
AXSM
Axsome Therapeutics, Inc
|
$207.75
|
$5.92B | - | 56 | Compare |
|
TGTX
TG Therapeutics, Inc.
|
$33.78
|
$5.80B | 12.1 | 56 | Compare |
|
KRYS
Krystal Biotech, Inc. Common Stock
|
$262.26
|
$5.20B | 38.1 | 55 | Compare |
|
PCVX
Vaxcyte, Inc. Common Stock
|
$57.24
|
$4.94B | - | 58 | Compare |
|
PTCT
PTC Therapeutics, Inc.
|
$65.06
|
$4.93B | 7.5 | 56 | Compare |
|
ARWR
Arrowhead Research Corporation
|
$73.48
|
$4.84B | 44.1 | 61 | Compare |
|
ACLX
Arcellx, Inc. Common Stock
|
$115.07
|
$4.55B | - | 57 | Compare |
|
PTGX
Protagonist Therapeutics, Inc
|
$98.97
|
$3.98B | - | 58 | Compare |
More CORT Analysis
Data updated: May 01, 2026 | Industry: Biotechnology (SIC 2834)
219 stocks in this industry